Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes
Annals of Internal Medicine · 2026-08 · 179 (8) · 1128-1139
DOI: 10.7326/annals-25-05216 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Internal Medicine, 2026-08. Verfasst von Kasia J Lipska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, and Veterans Affairs Cooperative Studies …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents, Insulin. Die Arbeit nennt 30 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, and Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Aff…
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut (K.Z.).
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, and Department of Biostatistics, Yale School of Pub…
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, and Department of Psychiatry, Yale University Schoo…
- Research and Development, Veterans Affairs Puget Sound Health Care System, and Divisions of Gastroenterology, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington (G.N.I.).
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, and Department of Internal Medicine, Yale School of…
ORCID-Profile: Lei Yan, Pradeep Mutalik, Barbara Gulanski
Zitieren
APA
Lipska, K. J., Zawack, K., Yan, L., Mutalik, P., Li, J., Gulanski, B., Ioannou, G. N., & Aslan, M. (2026). Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes. Annals of Internal Medicine, 179(8), 1128-1139. https://doi.org/10.7326/annals-25-05216
Vancouver
Lipska KJ, Zawack K, Yan L, Mutalik P, Li J, Gulanski B, et al. Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes. Annals of Internal Medicine. 2026;179(8):1128-1139. doi:10.7326/annals-25-05216
BibTeX
@article{Lipska2026,
author = {Lipska, Kasia J and Zawack, Kelson and Yan, Lei and Mutalik, Pradeep and Li, Jingmao and Gulanski, Barbara and Ioannou, George N and Aslan, Mihaela},
title = {Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes},
journal = {Annals of Internal Medicine},
year = {2026},
volume = {179},
number = {8},
pages = {1128--1139},
doi = {10.7326/annals-25-05216}
}
EUVIMED